治疗神经肌肉疾病:揭示基因治疗的突破,并开创未来的应用
Yu-Fu Wu1,2, Jun-An Chen3,4, Yuh-Jyh Jong5,6,7
1Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan. r02b22012@ntu.edu.tw.
Journal of biomedical science
|February 21, 2025
概括
腺关联病毒 (AAV) 基因疗法对治疗遗传神经肌肉疾病如脊髓肌肉缩 (SMA) 和杜恩肌肉缩 (DMD) 有前途. 需要进一步的研究来优化这些先进的治疗方法.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 神经学 神经学
背景情况:
- 遗传神经肌肉疾病 (NMDs) 在治疗和管理方面存在重大挑战.
- 基于腺相关病毒 (AAV) 的基因疗法已成为NMD的有前途的治疗策略.
- 脊柱肌缩 (SMA) 和杜申肌缩 (DMD) 是基因治疗干预的关键目标.
研究的目的:
- 审查基于AAV的基因疗法对遗传性NMD,特别是SMA和DMD的最新进展.
- 讨论当前FDA批准的基因疗法和有前途的临床前发现.
- 探索CRISPR/Cas9技术在NMD基因治疗的未来中的作用.
主要方法:
- 针对SMA和DMD的基于AAV的基因治疗研究的综合文献综述.
- 分析目前FDA批准的基因疗法及其疗效.
- 对新兴基于AAV的治疗方法的临床前数据的评估.
- 在NMD中探索CRISPR/Cas9基因编辑应用.
主要成果:
- 基于AAV的基因疗法正在显示出降低SMA严重性的潜力.
- 临床前研究表明,AAV载体在治疗DMD模型中有效.
- 克里斯普尔/Cas9技术为未来的NMD基因疗法提供了变革性的潜力.
结论:
- 在AAV基因疗法的开创性进展正在为遗传性NMDs的潜在治疗铺平道路.
- 开发强大的生物标志物对于指导治疗决策和预测结果至关重要.
- 本综述为开发用于NMD和其他神经退行性疾病的基因疗法提供了路线图.
关键词:
在 AAV AAV AAV 中.在ASO的基础上,ASO是ASO.在 DMD DMD 里面,你会发现基因治疗是一种基因疗法.运动神经元运动神经元这是一个NMD.在此期间,SMA SMA SMA更多相关视频
10:57Intramuscular Injections Along the Motor End Plates: A Minimally Invasive Approach to Shuttle Tracers Directly into Motor Neurons
Published on: July 13, 2015
12.6K
10:28Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
Published on: April 3, 2021
6.1K
相关概念视频
00:59Gene Therapy
25.1K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.1K
01:21Satellite Stem Cells and Muscular Dystrophy
1.9K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
1.9K
01:20Myasthenia Gravis: Overview and Treatment
1.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.1K
00:49What is Genetic Engineering?
73.2K
Overview
73.2K
01:29Neuromuscular Junction And Blockade
2.7K
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
2.7K